Proteins, Antibodies & ADCs
PART OF NEXTGEN BIOMED 2025
12 - 14 March 2025 | London, UK
NextGen Biomed 2025
Join leading scientific experts within proteins & antibodies, addressing critical strategies and the latest technological advancements in antibody discovery, nextgen therapeutics development, analytics and upstream & downstream bioprocessing updates.
Hear from past attendees of last year's Biologics 2024 conference
Gain valuable insights into novel strategies for cell line development & optimisation. Presentations will cover transposase mediated cell line generation, cell culturing techniques and advancing viral vector production through cell line development and engineering.
Gain a comprehensive understanding of downstream development for antibodies and Fc containing molecules. From Intensifying processes to improve productivity and reduce processing time, through to addressing protein aggregation challenges and single use technologies.
Discuss the latest novel tools & technologies for the display of biologics. Key opinion leaders will present on how to address difficult targets with display technologies as well as developing novel in vitro display technologies for antibody discovery & engineering.
Take a deep dive into novel clinical development strategies through engaging presentations on selecting patient population, ADC clinical development, designing clinical trials to get the best proof of concept & insights into non-oncology indications.
Tap into the latest in ADC optimisation to enhance therapeutic potential through exciting sessions on linker / payload technologies, conjugation strategies and more.
leading pharma, biotech, regulatory & academic delegates
Agenda at a Glance
Proteins, Antibodies & ADCs
DAY ONE - 12 MARCH
Track 1: Antibody Discovery & Selection: Novel Tools & Technologies
Track 2: ADC Design, Validation & Optimization to Enhance Their Therapeutic Potential
Track 3: Analytical Development: Stability & In-Depth Characterisation Methods for Proteins & Antibodies
Track 4: Upstream Development of Proteins & Antibodies: Novel Strategies for Cell Line Development & Expression Optimisation
DAY TWO - 13 MARCH
Track 1: Antibody Engineering & Selection
Track 2: New Formats: Cytokines, Immunocytokines & Novel Therapeutic Formats
Track 3: Emerging Analytical Techniques, Developability & Quality Control Systems
Track 4: Downstream Development for Antibodies and Fc Containing Molecules
DAY THREE - 14 MARCH
Track 1: AI/ML-Guided Protein & Antibody Engineering
Track 2: NextGen Multi-Specifics, Cell Engagers & Other New Modalities
Track 3: Novel Strategies for Clinical Development
Track 4: Novel Protein Process Development: Protein Purification & Recombinant Protein Production
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.